Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Updates

IVAC at 10: Assessing Access and Tackling Tough Challenges

February 2019

2019 marks IVAC’s 10th year as a center in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

Dr. Naor Bar-Zeev appointed as the new deputy director of IVAC

February 2019

The International Vaccine Access Center (IVAC) is pleased to announce that Naor Bar-Zeev, MBBS(Hons), MPH, MBiostat, PhD, has been appointed as the new deputy director of IVAC. Naor joined the IVAC team in 2017 as an Associate Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

Commentary: The economic burden of pneumonia, diarrhea, and measles is significant for households in Uganda

December 2018

The Decade of Vaccine Economics (DOVE) study has revealed significant household costs associated with childhood diseases and policy makers are taking notice.

Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

What We Do: Project highlights

The Pneumonia Etiology Research for Child Health (PERCH) study

The Pneumonia Etiology Research for Child Health (PERCH) study is a case-control study led by IVAC that enrolled 4,232 cases and 5,325 controls between 2011-2014 at 9 sites in 7 countries (The Gambia, Mali, Kenya, Zambia, South Africa, Bangladesh and Thailand). Read More >

Rotavirus Accelerated Vaccine Introduction Network (RAVIN)

The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) is a partnership led by Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), in collaboration with JSI and CDC, and is designed to provide policy, advocacy, and technical support to focus countries throughout the entire continuum of introducing rotavirus vaccine (RVV) – from the consideration and decision-making process to implementation and post-launch activities. Read More >

More Highlights